AAAAAA

   
Results: 1-7 |
Results: 7
RESEARCH PRIORITIES IN THE FIELD OF VACCINOLOGY
Authors: FRACCHIA GN
Citation: Gn. Fracchia, RESEARCH PRIORITIES IN THE FIELD OF VACCINOLOGY, Biologicals, 25(2), 1997, pp. 117-119
ROLE OF THE EUROPEAN-COMMISSION-IN-PHARMACEUTICALS-RESEARCH
Authors: FRACCHIA GN
Citation: Gn. Fracchia, ROLE OF THE EUROPEAN-COMMISSION-IN-PHARMACEUTICALS-RESEARCH, Biologicals, 22(4), 1994, pp. 333-334
SAFETY AND EFFICACY OF NEW-GENERATION VACCINES
Authors: CAPRON A LOCHT C FRACCHIA GN
Citation: A. Capron et al., SAFETY AND EFFICACY OF NEW-GENERATION VACCINES, Vaccine, 12(7), 1994, pp. 667-669
EFFICACY AND SAFETY OF CYTOKINES FOR HUMAN THERAPY - REPORT OF AN EC STUDY-GROUP
Authors: STRYCKMANS P DUFF GW FRACCHIA GN
Citation: P. Stryckmans et al., EFFICACY AND SAFETY OF CYTOKINES FOR HUMAN THERAPY - REPORT OF AN EC STUDY-GROUP, Cytokine, 5(3), 1993, pp. 180-184
RESEARCH PERSPECTIVES FOR A EUROPEAN CLINICAL-TRIALS NETWORK - REPORTFROM AN EC STUDY-GROUP
Authors: GARATTINI S FRACCHIA GN
Citation: S. Garattini et Gn. Fracchia, RESEARCH PERSPECTIVES FOR A EUROPEAN CLINICAL-TRIALS NETWORK - REPORTFROM AN EC STUDY-GROUP, Clinical trials and meta-analysis, 28(4-5), 1993, pp. 241-254
RESEARCH-AND-DEVELOPMENT OF INVITRO PHARMACOTOXICOLOGY - A EUROPEAN PERSPECTIVE
Authors: RODRIGUEZFARRE E ROBERFROID M FRACCHIA GN
Citation: E. Rodriguezfarre et al., RESEARCH-AND-DEVELOPMENT OF INVITRO PHARMACOTOXICOLOGY - A EUROPEAN PERSPECTIVE, ATLA. Alternatives to laboratory animals, 21(2), 1993, pp. 285-293
SAFETY AND EFFICACY OF THERAPEUTIC MONOCLONAL-ANTIBODIES IN CLINICAL-THERAPY
Authors: BACH JF FRACCHIA GN CHATENOUD L
Citation: Jf. Bach et al., SAFETY AND EFFICACY OF THERAPEUTIC MONOCLONAL-ANTIBODIES IN CLINICAL-THERAPY, Immunology today, 14(9), 1993, pp. 421-425
Risultati: 1-7 |